Close Menu

NEW YORK (GenomeWeb) – Illumina announced after the close of the market on Monday that a UK court has ruled that Ariosa Diagnostics infringed its patent covering a method for noninvasive prenatal testing.

The UK High Court of Justice, Chancery Division, Patents Court issued a judgment finding that Ariosa's Harmony cell-free, DNA-based NIPT infringes Illumina's European patent 1 524 321. The court also found the patent's claims were valid.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.